ReviewOncoTargets and therapy2018
New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab.
Olivier Bylicki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it
ReviewOncoTargets and therapy2018
Olivier Bylicki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.